Economic Daily-China Economic Net, Beijing, March 22 (Reporter Zhu Guowang) In recent years, social logistics companies have entered the field of drug distribution and improved the efficiency of drug logistics operations. But how to ensure that these non-professional drug-related logistics companies can distribute in compliance to ensure the quality and safety of drugs? On March 20, a reporter from the Economic Daily-China Economic Net learned from the China Pharmaceutical Business Association that the "Pharmaceutical Business Enterprise Logistics Service Capability Standards" and the "Medicine Logistics Quality and Service Capability Evaluation Standards for Pharmaceutical Transport Enterprises" formulated by the Association The on-site classification and grading assessment of 13 drug-related enterprises has been completed, and it is expected to be released as an industry standard by the Ministry of Commerce in six months. This will help China's pharmaceutical supply chain to achieve the goal of high-efficiency delivery with quality and safety as the cornerstone.

According to data provided by Zhu Jianyun, Secretary-General of the Pharmaceutical Supply Chain Branch of the China Pharmaceutical Business Association, the entire pharmaceutical logistics market in my country is conservatively estimated to be more than 100 billion yuan. This is not the amount of pharmaceutical circulation, but the income of pharmaceutical logistics. Zhu Jianyun said that 44% of this billion-dollar market is warehousing-related value-added services, and the remaining 56% is transportation. In other words, logistics and transportation account for more than half of the pharmaceutical logistics market.

Attracted by the market and driven by policies, my country's pharmaceutical circulation model is undergoing tremendous changes. Traditional pharmaceutical companies try to provide more professional pharmaceutical logistics, and many social logistics companies have also been involved in pharmaceutical logistics services. Traditional pharmaceutical commercial enterprises have a stronger awareness of product quality and safety, and they also have considerable experience in operating "Goods Management Practices for Pharmaceutical Business" (GSP) warehouses, but there are widespread resources in terms of logistics operation efficiency, trunk transportation and last-mile distribution And ability shortcomings. In contrast, social logistics companies have their own advantages in cost management and resource allocation. Their weaknesses are their inadequate understanding of the special requirements of the storage and transportation of the pharmaceutical industry, lack of quality awareness, and insufficient staffing of pharmaceutical expertise. However, the current lack of professional management of drug distribution companies in drug distribution management has led to many problems in compliance and safety in the operation of social logistics companies, which urgently need to be standardized and guided.

Zhu Jianyun said that in terms of pharmaceutical logistics, existing regulations and industry standards are relatively weak. There are many participants in drug-related transportation. Their professional capabilities include the controllability, guaranteeability, traceability and safety of drug-related transportation process management. There is no uniform standard. In the process of subcontracting and subcontracting the transportation process, There are unpredictable and difficult to control risks. She said that through a sample survey of 154 carriers from 55 pharmaceutical companies in 21 provinces, it was found that the carriers involved in the flow of drugs are relatively fragmented, lacking a compliant pharmaceutical transportation control system, and there is a great compliance risk.

At the beginning of 2017, under the guidance of the Ministry of Commerce, the China Pharmaceutical Commerce Association established a drafting group composed of experts from multinational pharmaceutical companies, pharmaceutical wholesalers and leading logistics companies, and completed the relevant "pharmaceutical business enterprise logistics service capability standards" and Drafting and revision of the standard of "Medicine Logistics Service Quality and Capability Evaluation Standards for Pharmaceutical Transport Enterprises". While submitting for review in the second half of 2018, the China Pharmaceutical Commerce Association organized some companies to carry out the pilot implementation of the standard. As of March 15, 2019, 13 drug-related logistics companies have been completed (8 drug-related business companies, 5 drug-related transportation companies) On-site classification and grading assessment work.

Cheng Junpei, vice president of China Pharmaceutical Commerce Association, said that from the results of the pilot evaluation and verification, the content of these two standards can stand scrutiny, and is also close to industry supervision, production companies choose third-party logistics service providers, and classification and grading guidance for pharmaceutical logistics companies. The requirements are fully implemented and implemented, laying a practical foundation for the official release of the Ministry of Commerce as an industry standard.

Cheng Junpei told a reporter from Economic Daily-China Economic Net that the specific terms and requirements of the classification and evaluation standards for drug flow classification are not only based on the requirements of GSP. At the beginning of the drafting period, the Standards Drafting Committee invited Johnson & Johnson, Sanofi, Novartis and other multinational pharmaceutical companies to participate, drawing on the advanced supply chain management concepts of multinational pharmaceutical companies, and integrating into the European and American GDP, the U.S. Supply Chain Security Act, and WHO’s support for pharmaceutical logistics services. Claim. Standards are forward-looking and are one of the powerful means to ensure the implementation of national health and safety strategies and supply chain strategies.

According to Zhu Jianyun, after the two standards were launched in the second half of last year, on the one hand, they will be tested first as association standards; on the other hand, they will be submitted for review as standards approved by the Ministry of Commerce. They are currently in the review stage and will be released after they pass the review. The process is expected to be officially released as an industry standard in about half a year.